Skip to main content

Vascular Access—Functional Arteriovenous Fistula (AVF) or AV Graft or Evaluation for Placement

CBE ID
0251
1.4 Project
Endorsed
Endorsement Status
1.1 New or Maintenance
E&M Cycle
Is Under Review
No
1.3 Measure Description

Percentage of end stage renal disease (ESRD) patients aged 18 years and older receiving hemodialysis during the 12-month reporting period and on dialysis >90 days who:

1. have a functional autogenous AVF (defined as two needles used or a single-needle device [NOT one needle used in a two-needle device]) (computed and reported separately);

2. have a functional AV graft (computed and reported separately); or

3. have a catheter, but have been seen/evaluated by a vascular surgeon, other surgeon qualified in the area of vascular access, or interventional nephrologist trained in the primary placement of vascular access for a functional autogenous AVF or AV graft at least once during the 12-month reporting period (computed and reported separately).

Reporting should be stratified by incident versus prevalent patients, as defined by USRDS.

        • 1.14 Numerator

          Number of patients from the denominator who:

          1. have a functional autogenous AVF (defined as two needles used or a single-needle device) (computed and reported separately); or

          2. have a functional AV graft (computed and reported separately); or

          3. have a catheter but have been seen/evaluated by a vascular surgeon, other surgeon qualified in the area of vascular access, or interventional nephrologist trained in the primary placement of vascular access for a functional autogenous AVF (defined as two needles used or a single needle device) or AV graft at least once during the 12-month reporting period (computed and reported separately).

          Reporting should be stratified by incident versus prevalent patients, as defined by USRDS.

        • 1.15 Denominator

          All ESRD patients aged 18 years and older receiving hemodialysis during the 12-month reporting period and on dialysis for greater than 90 days.

          This measure includes both in-center and home hemodialysis patients.

        • Exclusions

          None.

        • Most Recent Endorsement Activity
          Measure Retired and Endorsement Removed Renal Fall Cycle 2019
          Initial Endorsement
          Last Updated
          Removal Date